
Bain-backed Italmatch buys Norwegian startup Eco Inhibitors
Bain Capital-backed speciality chemicals company Italmatch Chemicals has acquired Norway-based Eco Inhibitors, which develops eco-friendly hydrate inhibitors for the oil & gas industry.
With the integration of Eco Inhibitors' technologies, Italmatch plans to diversify and expand its product range in the oil & gas industry. It will also manufacture and commercialise, through its Advanced Water Solutions business unit, three classes of biodegradable low-dosage hydrate inhibitors.
Italmatch generates annual revenues of €600m, employs a staff of 900 people and operates seven manufacturing plants based in Europe (Italy, Spain, Germany and UK), five in Asia (China, Japan and India), and five in the US, as well as several distribution subsidiaries located in Brazil, Belgium, China, Japan, India, Poland, Singapore and the US.
Bain Capital acquired Italmatch from Ardian in June 2018 in a deal reportedly valued at around €700m. The GP invested via its fourth Europe-focused fund, Bain Capital Europe IV, which held a final close in 2014 on €3.5bn.
The SBO ended a four-year holding period for Ardian, which bought a 67.7% stake in Italmatch from Mandarin Capital Partners and a minority holding from the Malacalza family in 2014, reaching a total ownership of 88%. The deal valued the company at around €220m at the time.
Previous funding
In 2012, Eco Inhibitors received funding from Wellwork Innovation, which invests in the development of new technologies within the oil & gas sector. As part of the deal, Wellwork partner Shona Grant joined the company's board as chair.
Company
Established in 2011 and based in Stavanger, Eco Inhibitors develops biodegradable and eco-friendly low-dosage hydrate inhibitors able to prevent hydrate formation and secure effective and sustainable transport of oil and gas. The company's inhibitors are produced from raw and natural materials, including recovered salmon waste.
People
Italmatch Chemicals – Sergio Iorio (CEO).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater